FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:FME - DE0005785802 - Common Stock
40.1 EUR
-0.37 (-0.91%)
We assign a fundamental rating of 5 out of 10 to FME. FME was compared to 27 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FME get a neutral evaluation. Nothing too spectacular is happening here. FME may be a bit undervalued, certainly considering the very reasonable score on growth Finally FME also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year FME was profitable.
In the past year FME had a positive cash flow from operations.
Each year in the past 5 years FME has been profitable.
In the past 5 years FME always reported a positive cash flow from operatings.
1.2 Ratios
FME has a Return On Assets of 2.33%. This is comparable to the rest of the industry: FME outperforms 40.74% of its industry peers.
Looking at the Return On Equity, with a value of 5.55%, FME is doing worse than 66.67% of the companies in the same industry.
FME has a Return On Invested Capital of 3.95%. This is in the lower half of the industry: FME underperforms 62.96% of its industry peers.
The Average Return On Invested Capital over the past 3 years for FME is below the industry average of 6.98%.
The last Return On Invested Capital (3.95%) for FME is above the 3 year average (3.14%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
The Profit Margin of FME (3.66%) is comparable to the rest of the industry.
FME's Profit Margin has declined in the last couple of years.
FME has a Operating Margin of 7.19%. This is comparable to the rest of the industry: FME outperforms 55.56% of its industry peers.
FME's Operating Margin has declined in the last couple of years.
FME has a Gross Margin (25.00%) which is in line with its industry peers.
FME's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
FME has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for FME remains at a similar level compared to 1 year ago.
The number of shares outstanding for FME has been reduced compared to 5 years ago.
Compared to 1 year ago, FME has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.20 indicates that FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
FME has a Altman-Z score (2.20) which is comparable to the rest of the industry.
FME has a debt to FCF ratio of 5.97. This is a neutral value as FME would need 5.97 years to pay back of all of its debts.
FME has a Debt to FCF ratio of 5.97. This is in the better half of the industry: FME outperforms 70.37% of its industry peers.
FME has a Debt/Equity ratio of 0.73. This is a neutral value indicating FME is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.73, FME is doing good in the industry, outperforming 62.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 2.2 |
ROIC/WACC0.7
WACC5.64%
2.3 Liquidity
A Current Ratio of 1.36 indicates that FME should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.36, FME is doing good in the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 1.00 indicates that FME may have some problems paying its short term obligations.
FME's Quick ratio of 1.00 is fine compared to the rest of the industry. FME outperforms 62.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.77%, which is quite good.
Measured over the past years, FME shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.43% on average per year.
FME shows a small growth in Revenue. In the last year, the Revenue has grown by 2.10%.
FME shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.04% yearly.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
The Earnings Per Share is expected to grow by 13.73% on average over the next years. This is quite good.
FME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.08% yearly.
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.73%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y4.08%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.66, the valuation of FME can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of FME indicates a rather cheap valuation: FME is cheaper than 92.59% of the companies listed in the same industry.
FME is valuated cheaply when we compare the Price/Earnings ratio to 26.37, which is the current average of the S&P500 Index.
FME is valuated reasonably with a Price/Forward Earnings ratio of 9.68.
Based on the Price/Forward Earnings ratio, FME is valued cheaper than 81.48% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of FME to the average of the S&P500 Index (36.20), we can say FME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.66 | ||
| Fwd PE | 9.68 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as FME.
Based on the Price/Free Cash Flow ratio, FME is valued a bit cheaper than 62.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.41 | ||
| EV/EBITDA | 10.51 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FME's earnings are expected to grow with 13.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y12.9%
EPS Next 3Y13.44%
5. Dividend
5.1 Amount
FME has a Yearly Dividend Yield of 3.50%. Purely for dividend investing, there may be better candidates out there.
FME's Dividend Yield is rather good when compared to the industry average which is at 2.04. FME pays more dividend than 100.00% of the companies in the same industry.
FME's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
5.2 History
The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
58.83% of the earnings are spent on dividend by FME. This is a bit on the high side, but may be sustainable.
FME's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.83%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
FRA:FME (12/4/2025, 5:36:15 PM)
40.1
-0.37 (-0.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.53B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts65.6
Price Target48.43 (20.77%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-3.8%
PT rev (3m)-4.91%
EPS NQ rev (1m)-1.78%
EPS NQ rev (3m)-4.91%
EPS NY rev (1m)0.52%
EPS NY rev (3m)0.42%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.66 | ||
| Fwd PE | 9.68 | ||
| P/S | 1.2 | ||
| P/FCF | 13.41 | ||
| P/OCF | 9.37 | ||
| P/B | 1.82 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.51 |
EPS(TTM)3.76
EY9.38%
EPS(NY)4.14
Fwd EY10.33%
FCF(TTM)2.99
FCFY7.46%
OCF(TTM)4.28
OCFY10.67%
SpS33.47
BVpS22.07
TBVpS-3.21
PEG (NY)0.58
PEG (5Y)N/A
Graham Number43.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROCE | 5.62% | ||
| ROIC | 3.95% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 11.65% | ||
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% | ||
| FCFM | 8.93% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 47.15% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 3.87 | ||
| Cash Conversion | 83.24% | ||
| Profit Quality | 244.33% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.2 |
F-Score5
WACC5.64%
ROIC/WACC0.7
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.73%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y4.08%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.66%
EBIT Next 3Y30.5%
EBIT Next 5Y18.68%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / FME.DE FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Undervalued.
What is the profitability of FME stock?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for FME stock?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 10.66 and the Price/Book (PB) ratio is 1.82.
Can you provide the dividend sustainability for FME stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 58.83%.